相关产品推荐更多 >

Goat Anti-Human kappa light chain antibody, pre-adsorbed (TRITC)
询价
Goat Anti-Human IgD (Heavy chain) antibody, pre-adsorbed (HRP)
¥1900
Goat Anti-Mouse IgG2c (Heavy chain) antibody, pre-adsorbed (FITC)
询价
Donkey anti-Sheep IgG antibody (Dylight488), pre-adsorbed
¥2500
Goat Anti-Mouse IgG antibody (DyLight680)
¥2300
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 免疫原:
Human IgG4 myeloma protein
- 亚型:
IgG1
- 形态:
Liquid
- 保存条件:
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE. Protect from light.
- 克隆性:
Monoclonal
- 标记物:
Purified IgG1
- 适应物种:
Human
- 保质期:
12 months from the shipping date of the product.
- 抗原来源:
0.1 mg/ml (Please refer to the vial label for the specific concentration.)
- 目录编号:
GTX04187-08
- 级别:
Secondary Antibodies
- 库存:
Available
- 供应商:
GeneTex
- 宿主:
Mouse
- 应用范围:
WB, ICC/IF, IHC-P, IHC-Fr, FACS, ELISA, Multiplexing, Purification
- 浓度:
0.1 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点:
Mouse Anti-Human IgG4 (Fc)
- 抗体英文名:
Mouse Anti-Human IgG4 (Fc) antibody [HP6025] (PE)
- 抗体名:
Mouse Anti-Human IgG4 (Fc) 抗体 [HP6025] (PE)
- 规格:
100 μg
ELISA analysis of purified human immunoglobulins using serially diluted GTX04187-08 Mouse Anti-Human IgG4 (Fc) antibody [HP6025] (PE).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验consists of a cooperation between monocytes and cytophilic antibodies able to bind to the Fc receptors present on the monocyte surface. Thus human IgG1 and IgG3 are the main isotypes effective in ADCI, whereas IgG2, IgG4, and IgM are ineffective
T-cell dependent antigen specific in situ staining (Pe)
6- Wash twice in TBS-T. 7- counterstain with rabbit anti B-Pe 1:2000 (0.5 µg/ml Cortex Biochem). You may add 1% mouse serum to the anti-Pe antibodies, unless you plan to use mouse monoclonal further (see below). 8- wash twice in TBS-T. 9- block
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料






